Corpus Intelligence IC Memo — HCA FLORIDA CAPITAL HOSPITAL 2026-04-26 12:30 UTC
IC Memo — HCA FLORIDA CAPITAL HOSPITAL
Investment Committee Memorandum | FL | 268 beds | Grade C | EBITDA uplift $25.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HCA FLORIDA CAPITAL HOSPITAL

CCN 100254 | LEON, FL | 268 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HCA FLORIDA CAPITAL HOSPITAL is a 268-bed suburban community hospital in LEON, FL with $341.7M in net patient revenue and a 34.5% operating margin. The hospital serves a payer mix of 17.6% Medicare, 2.8% Medicaid, and 79.6% commercial.

Thesis: Platform Growth. Our ML models identify $25.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 34.5% to 41.9% (+736bps).

Net Revenue HCRIS$341.7M
Current EBITDA COMPUTED$117.9M
Operating Margin COMPUTED34.5%
Occupancy HCRIS73.9%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS11.8%
Distress Probability ML40.4%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
109
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 34.5% places it above the state median. Among 109 size-comparable peers (134-536 beds), the median margin is 2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (134-536), prioritizing same-state peers. 109 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HCA FLORIDA CAPITAL HOSPITAL (Target)FL268$341.7M34.5%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
HCA FLORIDA OCALA HOSPITALFL509$761.7M27.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $25.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.2M+210bp18mo
Cost to Collect4.5%2.5%$6.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.2M+122bp9mo
Clean Claim Rate88.0%96.0%$219K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.2M
Cost to Collect
$6.8M
Denial Rate Reduction
$6.8M
A/R Days Reduction
$4.2M
Clean Claim Rate
$219K
Total EBITDA Uplift$25.2M
Current EBITDA$117.9M
+ RCM Uplift+$25.2M
Pro Forma EBITDA$143.0M
Current Margin34.5%
Pro Forma Margin41.9%
WC Released (1x)$13.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$181.3M$1.03B5.67x41.5%
Base (11x exit)10.0x11.0x$181.3M$1.19B6.57x45.7%
Bull Case9.0x11.0x$163.2M$1.33B8.17x52.2%
Bull (12x exit)9.0x12.0x$163.2M$1.50B9.20x55.9%
Bear Case11.0x10.0x$199.5M$844.3M4.23x33.5%
Bear (11x exit)11.0x11.0x$199.5M$993.5M4.98x37.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 109 hospitals with 134-536 beds
  • Same-state prioritization (n=110)
  • Comp margins: P25=-4.9% / P50=2.8% / P75=16.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.